These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4301249)

  • 1. Corticotrophin treatment in multiple sclerosis.
    Rinne UK; Sonninen V; Tuovinen T
    Acta Neurol Scand; 1968; 44(2):207-18. PubMed ID: 4301249
    [No Abstract]   [Full Text] [Related]  

  • 2. The assessment of adrenal-cortical function in patients receiving corticotrophin therapy.
    Levell MJ; Stitch SR; Noronha M; Vas C
    Acta Endocrinol (Copenh); 1970 Jun; 64(2):287-94. PubMed ID: 4317517
    [No Abstract]   [Full Text] [Related]  

  • 3. Corticotrophin treatment in multiple sclerosis.
    Rinne UK; Sonninen V; Tuovinen T
    Acta Neurol Scand; 1967; 43(S31):185-6. PubMed ID: 4296010
    [No Abstract]   [Full Text] [Related]  

  • 4. Adrenocorticotrophic potency of long-acting corticotrophin preparations during long-term treatment of neurological patients.
    Rinne UK
    Ann Med Intern Fenn; 1968; 57(4):167-72. PubMed ID: 4307479
    [No Abstract]   [Full Text] [Related]  

  • 5. ACTH-induced adrenocortical response patterns in multiple sclerosis and their relation to the clinical effectiveness of ACTH therapy.
    Alexander L; Cass LJ
    Confin Neurol; 1971; 33(1):1-24. PubMed ID: 4323739
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of adrenal and pituitary stimulation tests in patients with multiple sclerosis.
    Ketelaer CJ; Delmotte P
    Acta Neurol Scand; 1972; 48(4):467-78. PubMed ID: 4342093
    [No Abstract]   [Full Text] [Related]  

  • 7. Tetracosactrin in the treatment of rheumatic diseases.
    Balmer VG
    Med J Aust; 1972 Jun; 1(24):1271. PubMed ID: 4338983
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenocortical secretion capacity during long-term corticotrophin treatment of neurological patients.
    Kytömäki O; Rinne UK
    Acta Neurol Scand; 1970; 46(S43):263-4. PubMed ID: 4318676
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term treatment of multiple sclerosis with corticotrophin.
    Millar JH; Vas CJ; Noronha MJ; Liversedge LA; Rawson MD
    Lancet; 1967 Aug; 2(7513):429-31. PubMed ID: 4166100
    [No Abstract]   [Full Text] [Related]  

  • 10. Corticotrophin secreetion capacity after long-term corticotrophin treatment in multiple sclerosis.
    Rinne UK
    Ann Med Intern Fenn; 1968; 57(2):85-9. PubMed ID: 4303233
    [No Abstract]   [Full Text] [Related]  

  • 11. Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs placebo in acute exacerbation.
    Rose AS; Kuzma JW; Kurtzke JF; Sibley WA; Tourtellotte WW
    Trans Am Neurol Assoc; 1969; 94():126-33. PubMed ID: 4313957
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of long-acting synthetic corticotrophin in hypersensitive asthmatics and normal subjects.
    el-Shaboury AH
    Br Med J; 1968 Sep; 3(5619):653-5. PubMed ID: 4299775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind study of the effect of corticotropin treatment in multiple sclerosis.
    Boman K; Hokkanen E; Jarho L; Kivalo E
    Ann Med Intern Fenn; 1966; 55(3):71-3. PubMed ID: 4290702
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of pantethine on the function of the adrenal cortex. 2. Clinical experience using pantethine in cases under steroid hormone treatment].
    Onuki M; Suzawa A
    Horumon To Rinsho; 1970 Nov; 18(11):937-40. PubMed ID: 4320823
    [No Abstract]   [Full Text] [Related]  

  • 15. A critical evaluation and review of ACTH (corticotrophin) in the treatment of acute exacerbations of multiple sclerosis.
    Blustein H; Wasserman RR; Halperin L; Garvin JS
    Med Times; 1969 Dec; 97(12):137-41. PubMed ID: 4312534
    [No Abstract]   [Full Text] [Related]  

  • 16. Report of a new long-acting (Zn) synthetic ACTH (CIBA 36716 Ba-24 corticotrophin) on adrenal secretion in human subjects.
    Gilboa Y; Ber A; Winkelsberg G
    J Clin Endocrinol Metab; 1966 Jun; 26(6):666-8. PubMed ID: 4287990
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical tests of a new long-acting form of synthetic ACTH: Cortrosyn Depot].
    Libon JC; Borlée J
    Rev Med Liege; 1969 Nov; 24(21):762-5. PubMed ID: 4316477
    [No Abstract]   [Full Text] [Related]  

  • 18. Corticotrophin secretion capacity in multiple sclerosis.
    Rinne UK
    Eur Neurol; 1968; 1(4):221-33. PubMed ID: 4301627
    [No Abstract]   [Full Text] [Related]  

  • 19. Current methods of therapy in multiple sclerosis.
    Sibley WA
    Mod Treat; 1970 Sep; 7(5):918-29. PubMed ID: 4326377
    [No Abstract]   [Full Text] [Related]  

  • 20. ACTH vs. corticosteroids in therapy-utilize one and-or the other?
    Brandon ML
    Ann Allergy; 1972 May; 30(5):262-75. PubMed ID: 4336845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.